All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @lindsay_perry on TikTok · 49s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @lindsay_perry's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Okay, so I have been working more on the weekends.
  2. 0:04So something I have been using to help me is Cilank peptide.
  3. 0:08Cilank is a Russian peptide that helps with memory, attention,
  4. 0:12calming neurotransmitters, clearing neurotransmitters, and overall anxiety.
  5. 0:18It also increases BDNF or brain-derived
  6. 0:22neurotrophic factor, which is a protein that supports your
  7. 0:26neurons and also supports the growth of new neurons.
  8. 0:30This peptide is also a nasal spray, so I know a lot of people want to use peptides,
  9. 0:34but they don't want to inject, so this may be a good one for you.
  10. 0:38The only downside is that you can see there's not a lot in this bottle,
  11. 0:43and I really haven't used a lot. So it can get pretty pricey if you want to use it daily.

Peptide therapy TikTok claims: what the science actually supports

yourfunctionalnutritioncoach

TikTok creator

23.8K viewsWatch on TikTok

Quick answer

Selank is a synthetic anxiolytic heptapeptide developed in Russia with early-phase clinical data suggesting effects on GABAergic signaling and BDNF expression, primarily from small Russian trials that have not been independently replicated at scale. It is not FDA-approved and is available in the U.S. only through licensed compounding channels under provider supervision. Intranasal delivery has pharmacological rationale for CNS access, but human efficacy data for anxiety and memory in healthy adults remains limited.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptide therapy TikTok claims: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Peptide therapy TikTok claims: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Peptide therapy TikTok claims: what the science actually supports" from yourfunctionalnutritioncoach. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Selank is a synthetic anxiolytic heptapeptide developed in Russia with early-phase clinical data suggesting effects on GABAergic signaling and BDNF expression, primarily from small Russian trials that have not been independently replicated at scale.

The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7399335481856609566." In this clip, the useful excerpt is: "Okay, so I have been working more on the weekends." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Emerging pharmacotherapies for obesity: A systematic review (2025), Glucagon-like receptor agonists and next-generation incretin-based medications (2026), and Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The primary anxiety research comes from Russian clinical trials with small sample sizes.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Selank is a synthetic anxiolytic heptapeptide developed in Russia with early-phase clinical data suggesting effects on GABAergic signaling and BDNF expression, primarily from small Russian trials that have not been independently replicated at scale.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Selank is a synthetic anxiolytic heptapeptide developed in Russia with early-phase clinical data suggesting effects on GABAergic signaling and BDNF expression, primarily from small Russian trials that have not been independently replicated at scale. It is not FDA-approved and is available in the U.S. only through licensed compounding channels under provider supervision. Intranasal delivery has pharmacological rationale for CNS access, but human efficacy data for anxiety and memory in healthy adults remains limited.
  • Selank is not FDA-approved. In the U.S. it is only legally available through licensed compounding pharmacies with a valid provider prescription.
  • The primary anxiety research comes from Russian clinical trials with small sample sizes. No large independent Western replication trials currently exist.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Selank is not FDA-approved. In the U.S. it is only legally available through licensed compounding pharmacies with a valid provider prescription.
  • The primary anxiety research comes from Russian clinical trials with small sample sizes. No large independent Western replication trials currently exist.
  • Selank's mechanism involves GABAergic modulation and enkephalinase inhibition, not simple neurotransmitter clearance as implied in the video.
  • BDNF upregulation by selank is supported in rodent studies (Inozemtseva et al., 2008), but the jump to human neurogenesis benefits is not yet clinically established.
  • Intranasal delivery has real pharmacokinetic advantages for CNS-targeting peptides, as the olfactory pathway can bypass the blood-brain barrier (Dhuria et al., 2010, Journal of Pharmaceutical Sciences).
  • Anxiety and cognitive symptoms that affect daily life are clinical problems that warrant evaluation by a licensed provider, not self-directed peptide supplementation based on social media content.
  • Cost is a legitimate barrier. Compounded selank used daily can exceed $100 per month, and no insurance coverage exists for unapproved compounded peptides.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @lindsay_perry actually say?

Lindsay described selank as a "Russian peptide" that helps with "memory, attention, calming neurotransmitters" and "overall anxiety." She also claimed it increases BDNF, which she correctly identified as a protein that supports neurons and "the growth of new neurons." On a practical note, she flagged that selank comes as a nasal spray, positioning it as a needle-free alternative for people who want to try peptides without injecting.

She also acknowledged cost as a real barrier, noting the bottle doesn't last long if you use it daily. No dosing claims, no disease cure claims. Pretty restrained for TikTok peptide content, honestly.

Does the science back this up?

The short answer: partially, and mostly in animal models. The human data is thin, mostly from Russian clinical literature that hasn't been independently replicated in large Western trials. That matters more than most selank promoters admit.

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin. Russian researchers at the Institute of Molecular Genetics developed it in the 1990s, and early clinical studies conducted in Russia did suggest anxiolytic effects. Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) reported reduced anxiety and improved cognitive function in patients with anxiety-asthenic disorders. However, the trial sizes were small and the methodology wouldn't pass muster in a typical FDA submission.

On BDNF: Inozemtseva et al. (2008, Doklady Biological Sciences) found selank modulated BDNF expression in rat brain tissue, which is consistent with Lindsay's claim. But modulating BDNF expression in a rat hippocampus and "growing new neurons" in a human brain are not the same sentence.

What did they get wrong (or right)?

She got the mechanism framing mostly right. Selank does appear to influence the GABAergic system, which is the primary calming neurotransmitter system, and the enkephalinase inhibition pathway, which affects anxiety-related signaling. Saying it helps with "calming neurotransmitters" is a reasonable lay summary, not misinformation.

What's missing: she described it as helping to "clear" neurotransmitters, which is vague enough to be confusing. Selank's mechanism isn't primarily about clearing transmitters. It's more accurately about modulating breakdown of enkephalins and influencing GABA receptor sensitivity. The word "clearing" could mislead people into thinking it works like a stimulant or detox product.

The BDNF claim is accurate as far as it goes, but the leap from "increases BDNF" to cognitive enhancement in healthy humans is not supported by current evidence. BDNF is genuinely important for neuroplasticity, but oral and even nasal administration of peptides faces significant bioavailability questions that Lindsay didn't mention at all.

  • The "Russian peptide" framing is accurate and worth noting because it explains why the research base is narrow and hard to verify independently.
  • The nasal spray benefit claim is real. Intranasal delivery does bypass first-pass metabolism and may improve CNS delivery compared to oral routes.
  • The cost acknowledgment is honest and useful.

What should you actually know?

Selank is not FDA-approved. In the United States, it's available through compounding pharmacies operating under specific regulatory frameworks, and that status can change. If you're considering it, the conversation has to start with a licensed provider who can evaluate whether it's appropriate for your specific situation, not a TikTok video.

The anxiety and cognitive research is real but limited. Cornélissen et al. and independent Western replications of the Russian clinical data simply don't exist yet in meaningful numbers. That's not a reason to dismiss the research, but it is a reason to be honest about the confidence level. "Promising in early research" is not the same as "clinically validated."

The nasal route matters. Intranasal peptide delivery has legitimate pharmacological rationale. Dhuria et al. (2010, Journal of Pharmaceutical Sciences) reviewed evidence that intranasal administration can deliver peptides to the CNS via the olfactory pathway, which does give selank's delivery format more credibility than, say, an oral capsule of the same compound.

If anxiety or cognitive issues are affecting your daily functioning, those are clinical symptoms that deserve a real clinical evaluation, not a peptide purchase from a research chemical supplier.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

yourfunctionalnutritioncoach · TikTok creator

23.8K views on this video

Peptide therapy TikTok claims: what the science actually supports

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about selank?

Selank is not FDA-approved. In the U.S. it is only legally available through licensed compounding pharmacies with a valid provider prescription.

What does the video say about the primary anxiety research comes from russian clinical trials with?

The primary anxiety research comes from Russian clinical trials with small sample sizes. No large independent Western replication trials currently exist.

What does the video say about selank's mechanism involves gabaergic modulation?

Selank's mechanism involves GABAergic modulation and enkephalinase inhibition, not simple neurotransmitter clearance as implied in the video.

What does the video say about bdnf upregulation by selank?

BDNF upregulation by selank is supported in rodent studies (Inozemtseva et al., 2008), but the jump to human neurogenesis benefits is not yet clinically established.

What does the video say about intranasal delivery has real pharmacokinetic advantages for cns-targeting peptides, as?

Intranasal delivery has real pharmacokinetic advantages for CNS-targeting peptides, as the olfactory pathway can bypass the blood-brain barrier (Dhuria et al., 2010, Journal of Pharmaceutical Sciences).

What does the video say about anxiety?

Anxiety and cognitive symptoms that affect daily life are clinical problems that warrant evaluation by a licensed provider, not self-directed peptide supplementation based on social media content.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by yourfunctionalnutritioncoach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.